ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 76455 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 76455; 2) Community: the network communities that were significantly associated with the response to NSC 76455; 3) Molecule: the relationships between components within communities and NSC 76455; 4) MDR: the compounds that were significantly associated with the NSC 76455.

NSC Compound Enrichment Correlation
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0237269271456697 0.19943846
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.0237269271456697 0.065836828
NSC 105132 Deoxycamptothecin 0.029142074732756 0.099306957
NSC 134723 K 31 0.029142074732756 0.04392381
NSC 135962 Aracytidine 5'-palmitate 0.029142074732756 0.18794892
NSC 15795 Null 0.029142074732756 -0.011813986
NSC 261726 ICN 4221 0.029142074732756 0.046700343
NSC 28608 Null 0.029142074732756 0.35939607
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.029142074732756 0.090180563
NSC 629971 Camptothecin Derivative 0.029142074732756 0.074646367
Total:53  Current:30    [First] [Prev] [Next] [Last]